Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 111 In -pentetreotide
2. 111-indium-pentetreotide
3. In-111 Pentetreotide
4. Indium Ln-111 Pentetreotide
5. Indium-pentetreotide
6. Octreoscan
7. Octreoscan 111
8. Pentetreotide
1. 159201-00-0
2. Indium In 111 Pentetreotide [usan]
3. 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)
4. Octreoscan (tn)
5. Indium In 111 Pentetreotide (usp)
6. Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide Cyclic (3-8)-disulfidato(4-))-, Hydrogen, (r-(r*,r*))-
7. 139096-04-1
8. D02108
Molecular Weight | 1506.4 g/mol |
---|---|
Molecular Formula | C63H84InN13O19S2 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 25 |
Rotatable Bond Count | 30 |
Exact Mass | 1505.4486636 g/mol |
Monoisotopic Mass | 1505.4486636 g/mol |
Topological Polar Surface Area | 556 Ų |
Heavy Atom Count | 98 |
Formal Charge | 0 |
Complexity | 2570 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 10 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Octreoscan |
PubMed Health | Indium In 111 Pentetreotide (Injection) |
Drug Classes | Diagnostic Agent, Radiopharmaceutical Imaging |
Active Ingredient | Indium in-111 pentetreotide kit |
Dosage Form | Injectable |
Route | Injection |
Strength | 3mci/ml |
Market Status | Prescription |
Company | Mallinckrodt |
2 of 2 | |
---|---|
Drug Name | Octreoscan |
PubMed Health | Indium In 111 Pentetreotide (Injection) |
Drug Classes | Diagnostic Agent, Radiopharmaceutical Imaging |
Active Ingredient | Indium in-111 pentetreotide kit |
Dosage Form | Injectable |
Route | Injection |
Strength | 3mci/ml |
Market Status | Prescription |
Company | Mallinckrodt |
ABOUT THIS PAGE
61
PharmaCompass offers a list of Octreoscan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Octreoscan manufacturer or Octreoscan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Octreoscan manufacturer or Octreoscan supplier.
PharmaCompass also assists you with knowing the Octreoscan API Price utilized in the formulation of products. Octreoscan API Price is not always fixed or binding as the Octreoscan Price is obtained through a variety of data sources. The Octreoscan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A INDIUM IN-111 PENTETREOTIDE KIT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of INDIUM IN-111 PENTETREOTIDE KIT, including repackagers and relabelers. The FDA regulates INDIUM IN-111 PENTETREOTIDE KIT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. INDIUM IN-111 PENTETREOTIDE KIT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A INDIUM IN-111 PENTETREOTIDE KIT supplier is an individual or a company that provides INDIUM IN-111 PENTETREOTIDE KIT active pharmaceutical ingredient (API) or INDIUM IN-111 PENTETREOTIDE KIT finished formulations upon request. The INDIUM IN-111 PENTETREOTIDE KIT suppliers may include INDIUM IN-111 PENTETREOTIDE KIT API manufacturers, exporters, distributors and traders.
click here to find a list of INDIUM IN-111 PENTETREOTIDE KIT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A INDIUM IN-111 PENTETREOTIDE KIT DMF (Drug Master File) is a document detailing the whole manufacturing process of INDIUM IN-111 PENTETREOTIDE KIT active pharmaceutical ingredient (API) in detail. Different forms of INDIUM IN-111 PENTETREOTIDE KIT DMFs exist exist since differing nations have different regulations, such as INDIUM IN-111 PENTETREOTIDE KIT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A INDIUM IN-111 PENTETREOTIDE KIT DMF submitted to regulatory agencies in the US is known as a USDMF. INDIUM IN-111 PENTETREOTIDE KIT USDMF includes data on INDIUM IN-111 PENTETREOTIDE KIT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The INDIUM IN-111 PENTETREOTIDE KIT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of INDIUM IN-111 PENTETREOTIDE KIT suppliers with USDMF on PharmaCompass.
INDIUM IN-111 PENTETREOTIDE KIT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of INDIUM IN-111 PENTETREOTIDE KIT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right INDIUM IN-111 PENTETREOTIDE KIT GMP manufacturer or INDIUM IN-111 PENTETREOTIDE KIT GMP API supplier for your needs.
A INDIUM IN-111 PENTETREOTIDE KIT CoA (Certificate of Analysis) is a formal document that attests to INDIUM IN-111 PENTETREOTIDE KIT's compliance with INDIUM IN-111 PENTETREOTIDE KIT specifications and serves as a tool for batch-level quality control.
INDIUM IN-111 PENTETREOTIDE KIT CoA mostly includes findings from lab analyses of a specific batch. For each INDIUM IN-111 PENTETREOTIDE KIT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
INDIUM IN-111 PENTETREOTIDE KIT may be tested according to a variety of international standards, such as European Pharmacopoeia (INDIUM IN-111 PENTETREOTIDE KIT EP), INDIUM IN-111 PENTETREOTIDE KIT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (INDIUM IN-111 PENTETREOTIDE KIT USP).